Studies on kinetics of anturan excretion in man. 1979

W Seńczuk, and J Jodynis-Liebert

The kinetics of anturan excretion was studied. Experiments were carried out on ten healthy volunteers. The drug was given orally once applying three different doses: 100, 200, 400 mg. The contents of the drug in urine were determined by means of the modified method worked out by Wallace. It was found about 42 per cent of the dose was excreted with urine in an unchanged form. The process of anturan excretion may be described according to the one-compartment open kinetic model. The half-life of excretion is 3.5 hours, the excretion constant is 0.20. The formula showing the course of anturan excretion in time has been given. Five examples of the quantitative exposure test have been proposed; they allow the calculation of the absorbed drug dose and thus the degree of poisoning. The test can be also helpful in controlled therapy.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012737 Sex Factors Maleness or femaleness as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or effect of a circumstance. It is used with human or animal concepts but should be differentiated from SEX CHARACTERISTICS, anatomical or physiological manifestations of sex, and from SEX DISTRIBUTION, the number of males and females in given circumstances. Factor, Sex,Factors, Sex,Sex Factor
D013442 Sulfinpyrazone A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties. Sulfoxyphenylpyrazolidin,Anturan,Anturane,Apo-Sulfinpyrazone,Nu-Sulfinpyrazone,Sulphinpyrazone,Apo Sulfinpyrazone,Nu Sulfinpyrazone
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

W Seńczuk, and J Jodynis-Liebert
February 1987, International journal of clinical pharmacology, therapy, and toxicology,
W Seńczuk, and J Jodynis-Liebert
January 1968, Strahlentherapie. Sonderbande,
W Seńczuk, and J Jodynis-Liebert
October 1965, The Journal of pharmacy and pharmacology,
W Seńczuk, and J Jodynis-Liebert
December 1975, European journal of clinical pharmacology,
W Seńczuk, and J Jodynis-Liebert
November 1961, Toxicology and applied pharmacology,
W Seńczuk, and J Jodynis-Liebert
March 1940, The Journal of clinical investigation,
W Seńczuk, and J Jodynis-Liebert
October 1980, British journal of clinical pharmacology,
W Seńczuk, and J Jodynis-Liebert
April 1965, Canadian Medical Association journal,
W Seńczuk, and J Jodynis-Liebert
January 1967, Blood,
W Seńczuk, and J Jodynis-Liebert
January 1969, Bibliotheca haematologica,
Copied contents to your clipboard!